Checkpoint Inhibitors in Cancer Therapy: Clinical Benefits for Head and Neck Cancers

SIMPLE SUMMARY: In recent years, checkpoint inhibitor treatment of tumors has caused a stir. The response of patients with metastases showed outstanding success for some cancer types. However, many tumor types develop resistance strategies to evade this therapeutic application. This review provides...

Descripción completa

Detalles Bibliográficos
Autores principales: Ettl, Tobias, Grube, Matthias, Schulz, Daniela, Bauer, Richard Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599671/
https://www.ncbi.nlm.nih.gov/pubmed/36291769
http://dx.doi.org/10.3390/cancers14204985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599671/
https://www.ncbi.nlm.nih.gov/pubmed/36291769
http://dx.doi.org/10.3390/cancers14204985

Ejemplares similares